Columbus McKinnon Corporation

AI-generated fair value estimate for this company.

Method: Two-stage DCF on unlevered FCF

Reasoning: Base: normalized FY27 unlevered FCF ~$269M (adj. EBITDA guidance midpoint $400M, less ~$215M D&A for EBIT, 25% tax for NOPAT, plus back D&A, less ~$85M capex). Grown 5%/yr years 1-5 (organic + remaining synergy capture) and 3%/yr years 6-10; 2.5% terminal growth; 11% discount rate (reflects 5.1x net leverage post-Kito Crosby deal). EV ~$3.47B less ~$2.37B net debt (TTM debt $2.47B, cash $0.10B) = ~$1.10B equity value; divided by ~52M diluted shares (includes CD&R's ~42.5% as-converted preferred stake per FY27 guidance) = ~$21/share vs $16.61 market price as of Oct 2026